|Roth Capital Partners, LLC|
|Attn: Syndicate Department|
|24 Corporate Plaza|
|Newport Beach, CA 92660|
McKesson Corp. (MCK) hit a 52-week low Friday, falling 23% Friday, hitting $114 per share before bouncing back to $124.57 before market's close.
AstraZeneca, Bayer, Eli Lilly and Merck are just a few of the names that may join a bidding war for the cancer drug maker, analysts say.